Last reviewed · How we verify
NCT06195787
Improving Emergency Department Testing for Deep Vein Thrombosis
trial in Deep Vein Thrombosis (DVT) in 458 participants. Completed in 1 January 2025.
1 December 2024
Quick facts
| Lead sponsor | Dr. Kerstin de Wit |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 458 |
| Start date | 1 January 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Canada |
Conditions studied
- Deep Vein Thrombosis (DVT) — all drugs for Deep Vein Thrombosis (DVT) →
Sponsor
Dr. Kerstin de Wit
Who can join
18 and older, any sex, with Deep Vein Thrombosis (DVT). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study will use a new way to test for deep vein thrombosis (DVT) of the leg. A DVT is a blood clot in the leg and is a medical problem that can cause swelling, pain, and redness. If the blood clot is not treated, it can cause more serious, long-term effects, and occasionally lead to death. The main questions the study aims to answer are: 1. How safe is our new blood clot testing method? 2. How efficient is our new blood clot testing method? The study will be run in the emergency department and urgent care centre in Kingston, Ontario. Patients who are tested for a DVT in the leg can be included in the study. Researchers follow the patient through chart review to make sure the new system is safe and efficient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06195787
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deep Vein Thrombosis (DVT)
Currently open trials in the same condition.
- NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
- NCT07439991 — Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery · recruiting
Other Dr. Kerstin de Wit trials
Trials by the same sponsor.
- NCT07536906 — Falls Validation Study · not yet recruiting
- NCT06320236 — Emergency Medicine Pulmonary Embolism Testing Multicentre Study · recruiting
- NCT05708794 — Adjust-Unlikely PE · completed
- NCT05364749 — Selective CT for Anticoagulated Head Injured Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06195787 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. Kerstin de Wit
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06195787.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing